Development of targeted therapies in treatment of glioblastoma
Glioblastoma (GBM) is a type of tumor that is highly lethal despite maximal therapy. Standard therapeutic approaches provide modest improvement in progression-free and overall survival, necessitating the investigation of novel therapies. Oncologic therapy has recently experienced a rapid evolution t...
Main Authors: | Yuan-Yuan Xu, Pei Gao, Ying Sun, You-Rong Duan |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2015-09-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | http://www.cancerbiomed.org/index.php/cocr/article/view/874 |
Similar Items
-
Nanosensitizers for sonodynamic therapy for glioblastoma multiforme: current progress and future perspectives
by: Qing-Long Guo, et al.
Published: (2022-06-01) -
Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers
by: Nadin Rabah, et al.
Published: (2023-09-01) -
Medical Device Advances in the Treatment of Glioblastoma
by: Cher Ying Foo, et al.
Published: (2022-10-01) -
Advancements in nanoengineered paclitaxel formulations: A comprehensive review of blood-brain barrier infiltration strategies for glioblastoma therapy
by: Stabak Das, et al.
Published: (2024-06-01) -
Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma
by: Bryan G. Harder, et al.
Published: (2018-10-01)